Minerva Neurosciences Stock Analysis
| NERV Stock | USD 2.42 0.08 3.20% |
Minerva Neurosciences is overvalued with Real Value of 2.32 and Hype Value of 2.42. The main objective of Minerva Neurosciences stock analysis is to determine its intrinsic value, which is an estimate of what Minerva Neurosciences is worth, separate from its market price. There are two main types of Minerva Neurosciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Minerva Neurosciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Minerva Neurosciences' stock to identify patterns and trends that may indicate its future price movements.
The Minerva Neurosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Minerva Neurosciences is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Minerva Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Minerva Neurosciences' ongoing operational relationships across important fundamental and technical indicators.
Minerva |
Minerva Stock Analysis Notes
About 22.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.61. Minerva Neurosciences had not issued any dividends in recent years. The entity had 1:8 split on the 21st of June 2022. Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Minerva Neuroscie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. To find out more about Minerva Neurosciences contact the company at 617 600 7373 or learn more at https://www.minervaneurosciences.com.Minerva Neurosciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Minerva Neurosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Minerva Neurosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Minerva Neurosciences generated a negative expected return over the last 90 days | |
| Minerva Neurosciences has high historical volatility and very poor performance | |
| Minerva Neurosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (30.01 M) with loss before overhead, payroll, taxes, and interest of (16.84 M). | |
| Minerva Neurosciences currently holds about 40.22 M in cash with (14.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 22.0% of the company outstanding shares are owned by corporate insiders |
Minerva Neurosciences Upcoming and Recent Events
Earnings reports are used by Minerva Neurosciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Minerva Neurosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Minerva Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Minerva Neurosciences's market, we take the total number of its shares issued and multiply it by Minerva Neurosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 16th of April 2024, Minerva Neurosciences secures the Standard Deviation of 9.32, risk adjusted performance of (0.06), and Mean Deviation of 4.84. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Minerva Neurosciences, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Minerva Neurosciences, which can be compared to its peers in the industry. Please verify Minerva Neurosciences information ratio and kurtosis to decide if Minerva Neurosciences is priced some-what accurately, providing market reflects its recent price of 2.42 per share. Please also check out Minerva Neurosciences jensen alpha, which is currently at (1.03) to check the company can sustain itself at a future point.Minerva Neurosciences Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Minerva Neurosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Minerva Neurosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Minerva Neurosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Minerva Neurosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Minerva Neurosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Minerva Neurosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Remy Luthringer over two weeks ago Disposition of 18750 shares by Remy Luthringer of Minerva Neurosciences subject to Rule 16b-3 | ||
Race Geoff over six months ago Acquisition by Race Geoff of 87050 shares of Minerva Neurosciences subject to Rule 16b-3 | ||
Van Heek G Jan over six months ago Acquisition by Van Heek G Jan of 12500 shares of Minerva Neurosciences subject to Rule 16b-3 | ||
Race Geoff over six months ago Acquisition by Race Geoff of 46987 shares of Minerva Neurosciences subject to Rule 16b-3 |
Minerva Neurosciences Predictive Daily Indicators
Minerva Neurosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Minerva Neurosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Minerva Neurosciences Forecast Models
Minerva Neurosciences' time-series forecasting models are one of many Minerva Neurosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Minerva Neurosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Minerva Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Minerva Neurosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Minerva shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Minerva Neurosciences. By using and applying Minerva Stock analysis, traders can create a robust methodology for identifying Minerva entry and exit points for their positions.
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. Minerva Neuroscie operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Minerva Neurosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.